Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SG1002 in Heart Failure
NCT02278276Phase 2Unknown
- Sponsor
- Sulfagenix Inc.
- Start
- Apr 2016
- Primary completion
- Apr 2018
- Modality
- Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of sodium polysulthionate in heart failure (HF), sponsored by Sulfagenix Inc.. Status: unknown.
02
Drugs
sodium polysulthionate
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT02278276.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02278276.